Company: CDT
Filing Date: 2025-03-28
Form Type: 10-K
Source: 0001641172-25-001246
Chunk: 83

Company: CDT Equity Inc.
Filing Date: 2025-03-28
Form: 10-K
Item: Item 1A
Chunk 83
---
 meaning of Rule 16b-3 promulgated under the Exchange Act.

Nominating
and Governance Committee

The
Nominating and Corporate Governance Committee assists the board of directors with its oversight of and identification of individuals
qualified to become members of the board of directors, consistent with criteria approved by the board of directors, and selects, or recommends
that the board of directors selects, director nominees; develops and recommends to the board of directors a set of corporate governance
guidelines; oversees the evaluation of the board of directors; and reviews the environmental, safety, sustainability, and corporate social
responsibility policies, objectives, and practices on a periodic basis.

The
Nominating and Corporate Governance Committee is comprised of two members: Dr. Lewis-Hall (Chairperson) and Ms. Charles. The composition
of the Nominating and Corporate Governance Committee meets the requirements for independence under the current Nasdaq and SEC rules and
regulations.

Compensation
Committee Interlocks and Insider Participation

No
member of our Compensation Committee was at any time during fiscal year 2024, or at any other time, one of our officers or employees.
None of our executive officers have served as a director or member of a compensation committee (or other committee serving an equivalent
function) of any entity, one of whose executive officers served as a director of our board of directors or member of our Compensation
Committee.

Family
Relationships

There
are no family relationships among our directors and executive officers.

Code
of Conduct

We
adopted a written Code of Conduct applicable to all of our directors, officers, and employees, which is available on the Company’s
website at http://www.conduitpharma.com. Our Internet website address is provided as an inactive textual reference only. The Code of
Conduct covers fundamental ethical and compliance-related principles and practices such as accurate accounting records and financial
reporting, avoiding conflicts of interest, the protection and use of property and information, and compliance with legal and regulatory
requirements. The Code of Conduct is a “code of ethics,” as defined in Item 406(b) of Regulation S-K. The Company will make
any legally required disclosures regarding amendments to, or waivers of, provisions of its Code of Conduct on its corporate website.

Director
and Officer Liability and Indemnification

We
have purchased directors’ and officers’ liability insurance and have entered into indemnification agreements with each of
directors and executive officers. The indemnification agreements and our amended